|Articles|August 8, 2013

ChromaDex Acquires Second Pterostilbene Skin Care Patent

The acquisition brings the company’s total number of pterostilbene-related patents to eight.

ChromaDex Corp. (Irvine, CA) has obtained an eighth patent for its pTeroPure pterostilbene. The pterostilbene ingredient is a nature-identical form of this antioxidant found in blueberries. Chromadex now has worldwide pharmaceutical and cosmetic rights to use blueberry-sourced topical pterostilbene for prevention and/or treatment of skin diseases, damage, or injuries-including those relating to aging and exposure to the sun.

The patent marks the company’s second patent for pterostilbene and skin care. In September 2011, Chromadex came to terms with the University of California Irvine for exclusive rights to a different, joint patent.

From ingredient science to consumer trends, get the insights you need to stay competitive in the nutrition industry. Subscribe to Nutritional Outlook today.

ChromaDex Acquires Second Pterostilbene Skin Care Patent

Related Content

Expanding Women’s Wellness: Skin and Hair Health Research and Developments

New Vision for Women's Health: Trends and Innovation That Push the Category Forward

Fenugreek FAQ: An Evolving Women’s Health Ingredient

Symrise and Probi Highlight Biotic and Botanical Innovations, Signaling Expansion in Vascular and Postbiotic Categories

TopGum Expands US Manufacturing Footprint With Acquisition of PL Developments

Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends

A New Frontier in Eye Health: Digital Wellness, Bioavailability, and the Eye-Brain Connection

Finished Product Clinical Validation Emerges as a Competitive Differentiator in the Supplement Industry

Clasado Biosciences Partners with Prokopton SAS to Expand Bimuno GOS Distribution in France

Lion’s Mane Ingredient Targets Standardized Erinacine A

Puresource Appoints Andrea Benson as President